• 1
    Connelly LB, Woolf A, Brooks P. Cost-effectiveness of interventions for musculoskeletal conditions: disease control priorities in developing countries. 2nd ed. New York: Oxford Press; 2006. p. 96380.
  • 2
    Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 1993; 19: 12351.
  • 3
    Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos G. Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol 2004; 31: 5865.
  • 4
    Lassere M, Reitbergen M, Rappo J, Portek I, McGuigan L, Sturgess A, et al. Mortality and its predictors in patients with rheumatoid arthritis [abstract]. Arthritis Rheum 2004; 50 Suppl 9: S673.
  • 5
    Gordon DA, Hastings DE. Clinical features of rheumatoid arthritis. In: HochbergM, SilmanAJ, SmolenJS, WeinblattME, WeismanMH, editors. Rheumatology. 3rd ed. London: Mosby; 2003.
  • 6
    Yelin E. Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl 2003; 68: 811.
  • 7
    Australian Bureau of Statistics. National health survey: summary of results. 2006. URL:$File/43640_2004-05.pdf.
  • 8
    Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 2008; 58: 1525.
  • 9
    National Arthritis and Musculoskeletal Advisory Group. Evidence to support the National Action Plan for Osteoarthritis, Rheumatoid Arthritis and Osteoporosis: opportunities to improve health-related quality of life and reduce the burden of disease and disability. Canberra: Australian Government Department of Health and Ageing; 2004.
  • 10
    Mayer F, Ross N, Berthelot JM, Wilkins R. Disability-free life expectancy by health region. Health Rep 2002; 13: 4960.
  • 11
    Wang PP, Elsbett-Koeppen R, Geng G, Badley EM. Arthritis prevalence and place of birth: findings from the 1994 Canadian National Population Health Survey. Am J Epidemiol 2000; 152: 4425.
  • 12
    Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health 1984; 74: 5749.
  • 13
    Hawker GA, Wright JG, Glazier RH, Coyte PC, Harvey B, Williams JI, et al. The effect of education and income on need and willingness to undergo total joint arthroplasty. Arthritis Rheum 2002; 46: 33319.
  • 14
    Tugwell P, de Savigny D, Hawker G, Robinson V. Applying clinical epidemiological methods to health equity: the equity effectiveness loop. BMJ 2006; 332: 35861.
  • 15
    Bero L, Rennie D. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA 1995; 274: 19358.
  • 16
    Coukell A. Social science: try it and see. The Economist 2002 Feb 28.
  • 17
    Arblaster L, Lambert M, Entwistle V, Forster M, Fullerton D, Sheldon T, et al. A systematic review of the effectiveness of health service interventions aimed at reducing inequalities in health. J Health Serv Res Policy 1996; 1: 93103.
  • 18
    Gepkens A, Gunning-Schepers LJ. Interventions to reduce socioeconomic health differences [review]. Eur J Public Health 1996; 6: 21826.
  • 19
    Programme Committee on Socio-Economic Inequalities in Health-second phase. Reducing socio-economic inequalities in health: final report and recommendations from the Dutch Programme Committee on Socio-Economic Inequalities in Health-second phase. Den Haag: Zon MW; 2001.
  • 20
    Mackenbach JP, Stronks K. A strategy for tackling health inequalities in the Netherlands. BMJ 2002; 325: 102932.
  • 21
    Macintyre S. Evidence based policy making: impact on health inequalities still needs to be assessed. BMJ 2003; 326: 56.
  • 22
    Tugwell P, Petticrew M, Robinson V, Kristjansson E, Maxwell L, and the Cochrane Equity Field Editorial Team. Cochrane and Campbell Collaborations, and health equity. Lancet 2006; 365: 112830.
  • 23
    Tugwell P, O'Connor A, Andersson N, Mhatre S, Kristjansson E, Jacobsen MJ, et al. Reduction of inequalities in health: assessing evidence-based tools. Int J Equity Health 2006; 5: 11.
  • 24
    Kristjansson EA, Robinson V, Petticrew M, MacDonald B, Krasevec J, Janzen L, et al. School feeding for improving the physical and psychosocial health of disadvantaged elementary school children. Cochrane Database Syst Rev 2007; 1:CD004676.
  • 25
    Gwatkin DR, Bhuiya A, Victora CG. Making health systems more equitable. Lancet 2004; 364: 127380.
  • 26
    Casimiro L, Barnsley L, Brosseau L, Milne S, Robinson VA, Tugwell P, et al. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 2005; 4:CD003788.
  • 27
    Navarro-Sarabia F, Ariza-Ariza R, Hernandez-Cruz B, Villaneuva I. Adalimumab for treating rheumatoid arthritis. Cochrane Database Syst Rev 2005; 3:CD005113.
  • 28
    Verhagen AP, Bierma-Zeinstra SM, Boers M, Cardoso JR, Lambeck J, DeBie RA, et al. Balneotherapy for rheumatoid arthritis. Cochrane Database Syst Rev 2004; 1:CD000518.
  • 29
    Kirwan JR, Bijlsma JW, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev 2007; 1:CD006356.
  • 30
    Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, et al. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 2003; 3:CD004525.
  • 31
    Wallen M, Billies D. Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 2006; 1:CD002824.
  • 32
    Brosseau L, Robinson V, Wells G, DeBie R, Gam A, Harman K, et al. Low level laser therapy (classes I, II, and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev 2005; 4:CD002049.
  • 33
    Steultjens EM, Dekker J, Bouter LM, van Schaardenburg D, van Kuyk MA, van den Ende CM. Occupational therapy for rheumatoid arthritis. Cochrane Database Syst Rev 2004; 1:CD003114.
  • 34
    Wienecke T, Gotzsche PC. Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Cochrane Database Syst Rev 2004; 1:CD003789.
  • 35
    Riemsma RP, Kirwan JR, Taal E, Rasker JJ. Patient education for adults with rheumatoid arthritis. Cochrane Database Syst Rev 2003; 2:CD003688.
  • 36
    Garner SE, Fidan DD, Frankish RR, Judd MG, Towheed TE, Tugwell P, et al. Rofecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 2005; 1:CD003685.
  • 37
    Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Databsae Syst Rev 2005; 1:CD000189.
  • 38
    Han A, Judd MG, Robinson VA, Taixiang W, Tugwell P, Wells G. Tai chi for treating rheumatoid arthritis. Cochrane Database Syst Rev 2004; 3:CD004849.
  • 39
    Brosseau L, Yonge KA, Robinson V, Marchand S, Judd M, Wells G, et al. Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand. Cochrane Database Syst Rev 2003; 2:CD004377.
  • 40
    Evans T, Brown H. Road traffic crashes: operationalizing equity in the context of health sector reform. Inj Control Saf Promot 2003; 10: 112.
  • 41
    Goeppinger J, Arthur MW, Baglioni AJ Jr, Brunk SE, Brunner CM. A reexamination of the effectiveness of self-care education for persons with arthritis. Arthritis Rheum 1989; 32: 70616.
  • 42
    Savelkoul M, de Witte LP, Candel MJ, van der Tempel H, van den Borne B. Effects of a coping intervention on patients with rheumatic diseases: results of a randomized controlled trial. Arthritis Rheum 2001; 45: 6976.
  • 43
    Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 2001; 60: 86975.
  • 44
    Helliwell PS, O'Hara M, Holdsworth J, Hesselden A, King T, Evans P. A 12-month randomized controlled trial of patient education on radiographic changes and quality of life in early rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 3038.
  • 45
    Parker JC, Singsen BH, Hewett JE, Walker SE, Hazelwood SE, Hall PJ, et al. Educating patients with rheumatoid arthritis: a prospective analysis. Arch Phys Med Rehabil 1984; 65: 7714.
  • 46
    Parker JC, Frank RG, Beck NC, Smarr KL, Buescher KL, Phillips LR, et al. Pain management in rheumatoid arthritis patients: a cognitive-behavioral approach. Arthritis Rheum 1988; 31: 593601.
  • 47
    Kaplan S, Kozin F. A controlled study of group counseling in rheumatoid arthritis. J Rheumatol 1981; 8: 919.
  • 48
    Hall J, Skevington SM, Maddison PJ, Chapman K. A randomized and controlled trial of hydrotherapy in rheumatoid arthritis. Arthritis Care Res 1996; 9: 20615.
  • 49
    Stern EB, Ytterberg SR, Krug HE, Mullin GT, Mahowald ML. Immediate and short-term effects of three commercial wrist extensor orthoses on grip strength and function in patients with rheumatoid arthritis. Arthritis Care Res 1996; 9: 4250.
  • 50
    Barry MA, Purser J, Hazleman R, McLean A, Hazleman BL. Effect of energy conservation and joint protection education in rheumatoid arthritis. Br J Rheumatol 1994; 33: 11714.
  • 51
    Hass U, Brodin H, Andersson A, Persson J. Assistive technology selection: a study of participation of users with rheumatoid arthritis. IEEE Trans Rehabil Eng 1997; 5: 26375.
  • 52
    Gwatkin DR. The need for equity-oriented health sector reforms. Int J Epidemiol 2001; 30: 7203.
  • 53
    Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, et al. The causes and effects of socio-demographic exclusions from clinical trials. Heath Technol Assess 2005; 9: 1152.
  • 54
    Kelly MP, Morgan A, Bonnefoy J, Butt J, Bergman V. The social determinants of health: developing an evidence base for political action. Final Report to the World Health Organization Commission on the Social Determinants of Health from Measurement and Evidence Knowledge Network. 2007. URL:
  • 55
    D'Souza RM, D'Souza R. Vitamin A for treating measles in children. Cochrane Database Syst Rev 2003; 1:CD001479.
  • 56
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 72940.